completed its $40.0million program to repurchase sOmnicell,Inc. (Nasdaq:
OMCL), a leading provider of system solutions to acute healthcare facilities, announced today that it has completed its $40.0million program to repurchase shares of its Common Stock. A total of 2,133,898 shares were repurchased at an average price of $18.75.mARCH 12.2008
The stock is in uptrend with resistance at 21$. If $21 is breached it may test 22-23 area.